“…Inclusion criteria were age ≤55 years, defining young; nonlacunar carotid-territory infarction downstream from CaFMD; CaFMD as described above on computed tomographic angiography (CTA) images; no other stroke cause after comprehensive work-up, including brain MRI within 48 hours, transthoracic and transesophageal echocardiographies, 24-hour ECG Holter, routine biological tests, carotid and vertebral duplex ultrasound (DUS) and extracranial artery CTA; and no evidence of calcification or patent atherosclerosis of extraor intracranial arteries. This 5-year study had 2 phases: during part 1 (January 2008 to October 2011), CTA was done only when DUS visualized an echogenic bulbar outgrowth in the proximal internal carotid 5 ; during part 2 (November 2011 to February 2013), CTA was done systematically, regardless of DUS findings (if done). In addition, because of the observed high stroke-recurrence rate, despite antiplatelet therapy, and with local Ethics Committee approval, surgical CaFMD removal was proposed for incident and recurrent ischemic events, during part 2.…”